Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -32.85%554M | -34.26%825M | 37.76%1.26B | 196.09%911M | -59.17%307.68M | -6.67%753.48M | 94.49%807.29M | 34.97%415.09M | -28.68%307.55M | 431.21M |
Net profit before non-cash adjustment | -431.93%-1.74B | -44.77%523M | 101.49%947M | 99.81%470M | -69.79%235.22M | 6.27%778.56M | 58.52%732.64M | 98.20%462.16M | -43.21%233.19M | --410.63M |
Total adjustment of non-cash items | 571.93%2.3B | 28.09%342M | 9.43%267M | 52.35%244M | 1,557.27%160.16M | -80.25%9.66M | 97.69%48.93M | 126.11%24.75M | 1,066.11%10.95M | ---1.13M |
-Depreciation and amortization | 23.73%438M | 74.38%354M | 6.28%203M | 134.53%191M | 140.66%81.44M | -1.57%33.84M | 62.41%34.38M | 452.11%21.17M | -8.63%3.83M | --4.2M |
-Reversal of impairment losses recognized in profit and loss | --1.75B | --0 | ---- | ---- | --2.37M | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | --0 | -96.23%2M | -41.11%53M | 29.98%90M | --69.24M | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | 914.29%114M | -227.27%-14M | 129.73%11M | -620.17%-37M | 129.42%7.11M | -266.16%-24.18M | 306.20%14.55M | -49.63%3.58M | 233.46%7.11M | ---5.33M |
Changes in working capital | 71.43%-12M | -213.51%-42M | -80.83%37M | 320.05%193M | -152.47%-87.71M | -235.06%-34.74M | 135.81%25.72M | -213.27%-71.83M | 192.06%63.41M | --21.71M |
-Change in receivables | 36.84%26M | 137.25%19M | -126.15%-51M | 216.46%195M | -2,650.05%-167.44M | 107.87%6.57M | 16.59%-83.42M | -203.18%-100.01M | 237.69%96.94M | ---70.4M |
-Change in payables | 37.70%-38M | -169.32%-61M | 4,500.00%88M | -102.51%-2M | 293.02%79.73M | -137.85%-41.31M | 287.22%109.14M | 184.08%28.19M | -151.30%-33.52M | --65.34M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --26.77M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -33.33%-8M | -200.00%-6M | 0.00%-2M | -78.89%-2M | -1.12M | |||||
Interest received (cash flow from operating activities) | 0 | 0 | 0 | 0 | -8.70%21K | 27.78%23K | 100.00%18K | -93.66%9K | 49.47%142K | 95K |
Tax refund paid | 53.88%-226M | -84.21%-490M | -2,560.00%-266M | 96.77%-10M | 4.13%-309.92M | -40.62%-323.25M | -412.65%-229.87M | 72.91%-44.84M | -15.98%-165.53M | -142.72M |
Other operating cash inflow (outflow) | -1,500.00%-16M | 0.00%-1M | -1M | 0 | 0 | 0 | 0 | 33.61M | 0 | 1K |
Operating cash flow | -7.32%304M | -66.73%328M | 9.68%986M | 27,056.52%899M | -100.78%-3.34M | -25.49%430.25M | 42.98%577.44M | 184.09%403.86M | -50.74%142.16M | --288.59M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -525.00%-25M | -300.00%-4M | 96.77%-1M | -457.65%-31M | -189.68%-5.56M | -81.04%-1.92M | 34.97%-1.06M | -3.23%-1.63M | 33.49%-1.58M | ---2.37M |
Net intangibles purchase and sale | -65.22%-38M | -1,050.00%-23M | 71.43%-2M | 68.82%-7M | 49.02%-22.45M | ---44.04M | ---- | ---2.13M | ---- | ---- |
Net business purchase and sale | -57.51%-986M | -8,842.86%-626M | 98.83%-7M | 65.71%-600M | ---1.75B | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | ---- | ---- | ---49M | --0 | -735.33%-150.36M | ---18M | ---- | ---- | ---- | ---- |
Net changes in other investments | -1,860.00%-88M | 350.00%5M | -128.57%-2M | 116.45%7M | -52,432.10%-42.55M | -1.25%-81K | 99.94%-80K | ---132.8M | ---- | ---- |
Investing cash flow | -75.46%-1.14B | -962.30%-648M | 90.33%-61M | 67.98%-631M | -2,977.73%-1.97B | -5,517.37%-64.04M | 99.17%-1.14M | -8,548.39%-136.56M | 33.49%-1.58M | ---2.37M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -215.86%-453M | 250.38%391M | -189.66%-260M | -61.84%290M | --760M | ---- | ---- | ---- | ---- | ---- |
Net common stock issuance | --0 | ---131M | --0 | --0 | -16,128.93%-209.98M | 106.70%1.31M | -102.86%-19.56M | --684.27M | ---- | ---- |
Cash dividends paid | 1.96%-50M | ---51M | ---- | ---- | 97.37%-1.34M | ---50.81M | ---- | ---- | ---- | ---47.04M |
Net other fund-raising expenses | 50.00%-1M | -300.00%-2M | 200.00%1M | -99,900.00%-1M | ---1K | ---- | ---22.09M | ---- | ---- | ---- |
Financing cash flow | -343.48%-504M | 179.92%207M | -189.62%-259M | -47.33%289M | 1,208.41%548.68M | -18.85%-49.5M | -106.09%-41.65M | --684.27M | ---- | ---47.04M |
Net cash flow | ||||||||||
Beginning cash position | -4.63%2.33B | 39.83%2.44B | 47.01%1.75B | -54.58%1.19B | 13.79%2.61B | 30.34%2.3B | 117.42%1.76B | 20.99%810.42M | 55.54%669.83M | --430.66M |
Current changes in cash | -1,083.19%-1.34B | -116.97%-113M | 19.57%666M | 139.07%557M | -550.11%-1.43B | -40.76%316.71M | -43.81%534.65M | 576.87%951.57M | -41.22%140.58M | --239.17M |
Cash adjustments other than cash changes | ---- | ---- | -200.00%-1M | --1M | ---- | ---- | ---1K | ---- | ---- | ---- |
End cash Position | -57.46%990M | -3.44%2.33B | 38.11%2.41B | 46.91%1.75B | -54.55%1.19B | 13.79%2.61B | 30.34%2.3B | 117.42%1.76B | 20.99%810.42M | --669.83M |
Free cash flow | -19.93%241M | -69.38%301M | 15.51%983M | 2,815.03%851M | -108.16%-31.34M | -33.33%384.3M | 44.06%576.38M | 184.61%400.11M | -50.88%140.58M | --286.21M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |